Filing Details
- Accession Number:
- 0000904454-22-000532
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-11-01 19:58:26
- Reporting Period:
- 2022-10-28
- Accepted Time:
- 2022-11-01 19:58:26
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1178711 | Paratek Pharmaceuticals Inc. | PRTK | Pharmaceutical Preparations (2834) | 330960223 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1622680 | Evan Loh | C/O Paratek Pharmaceuticals, Inc. 75 Park Plaza, 4Th Floor Boston MA 02116 | Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2022-10-28 | 8,805 | $3.47 | 1,278,937 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of shares to cover personal income tax obligations upon vesting of performance-based restricted stock units, as previously reported in a Form 4 filed with the Securities and Exchange Commission (the "SEC") on October 27, 2022, pursuant to a Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions ranging from $3.43 to $3.55. The Reporting Person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote 2 to this Form 4.
Billionaire Hedge Funds
